SEC FILINGS
XPOF EDGAR Filing Record
Every material 8-K filing from Xponential Fitness, Inc. (XPOF) — annotated with coalition context connecting the events to the executives, creditors, and structural decisions behind them.
Sources: SEC EDGAR (CIK 0001802156). Coalition annotations represent analysis of public filings — they are not legal claims. All documents are public record.
35
Filings Catalogued
18
High Significance
35
EDGAR Verified
16
Entities Linked
SEC Filings Record
18 HIGH significanceXPOF 8-K filings from EDGAR — annotated by the coalition with context, connected entities, and structural significance. Newest first.
35 of 35 filings
2026
March 10, 2026
8-KItems 2.02, 5.02, 7.01, 9.01
CFO John Meloun Separated — Interim CFO Robert Julian Appointed
Executive ExitCFO DepartureLeadership Change
SEC ↗0001802156-26-000039
Click to read coalition annotation ↓
February 26, 2026
8-KItems 2.02, 9.01
Q4 2025 & Full-Year Earnings — First Results Under Nuzzo
EarningsFinancial Results
SEC ↗0001193125-26-076678
Click to read coalition annotation ↓
2025
December 8, 2025
8-KItems 1.01, 1.02, 2.03, 7.01, 8.01, 9.01
$525M Debt Refinancing — New Term Loan Replaces Prior Facility; Preferred Stock Eliminated
Debt RestructuringAres ConnectionBoard Governance
SEC ↗0001193125-25-311452
Click to read coalition annotation ↓
November 12, 2025
8-KItems 5.02, 7.01, 9.01
CLO Andrew Hagopian Separated — Gavin O'Connor (Ex-European Wax Center) Appointed
Executive ExitLegal CounselCLO Change
SEC ↗0001193125-25-276196
Click to read coalition annotation ↓
November 6, 2025
8-KItems 2.02, 9.01
Q3 2025 Earnings Report
EarningsFinancial Results
SEC ↗0001193125-25-269609
Click to read coalition annotation ↓
September 19, 2025
8-KItems 8.01, 9.01
Lindora Divested to Next Health Management Group, Inc.
Brand DivestitureLindoraNext Health
SEC ↗0001193125-25-208250
Click to read coalition annotation ↓
September 5, 2025
8-KItems 5.02
Board / Officer Personnel Change — September 2025
Personnel ChangeBoard Change
SEC ↗0001193125-25-196622
Click to read coalition annotation ↓
August 27, 2025
8-KItems 5.02, 9.01
Rachel Lee Appointed to Board — Former Partner & Head of Consumer PE, Ares Management
Board GovernanceAres ConnectionDebt Structure
SEC ↗0001193125-25-189246
Click to read coalition annotation ↓
August 7, 2025
8-KItems 2.02, 9.01
Q2 2025 Earnings — Mark King's Final Quarter as CEO
EarningsFinancial Results
SEC ↗0001193125-25-175426
Click to read coalition annotation ↓
August 7, 2025
8-KItems 5.02, 9.01
CEO Transition: Mark King Departs — Mike Nuzzo Appointed CEO
Executive ExitCEO TransitionLeadership Change
SEC ↗0001193125-25-175028
Click to read coalition annotation ↓
July 28, 2025
8-KItems 8.01, 9.01
CycleBar + Rumble Boxing Divested to Extraordinary Brands — Terms Undisclosed
Brand DivestitureCycleBarRumble BoxingExtraordinary Brands
SEC ↗0001193125-25-165934
Click to read coalition annotation ↓
April 25, 2025
DEF 14A
Proxy Statement — 2025 Annual Meeting
proxyexecutive-compensationrelated-partyGeisler
SEC ↗0001140361-25-015745
Click to read coalition annotation ↓
2024
November 26, 2024
10-K/A
Annual Report Amendment (10-K/A) — FY2023 Restatement
restatementFY2023amendmentSEC-review
SEC ↗0001193125-24-266130
Click to read coalition annotation ↓
November 26, 2024
10-Q/A
Quarterly Report Amendment (10-Q/A) — Q3 2024 Restatement
restatementQ3-2024amendmentSEC-review
SEC ↗0001193125-24-266131
Click to read coalition annotation ↓
November 4, 2024
CORRESP
SEC Staff Comment Letter — Final Round (Nov 2024)
SECCORRESPrestatementFY2023disclosure-challenge
SEC ↗0001193125-24-250835
Click to read coalition annotation ↓
September 24, 2024
CORRESP
SEC Staff Comment Letter — Round 4 (Sep 2024)
SECCORRESPFY2023disclosure-challenge
SEC ↗0001193125-24-224846
Click to read coalition annotation ↓
September 10, 2024
CORRESP
SEC Staff Comment Letter — Round 3 (Sep 2024)
SECCORRESPFY2023disclosure-challenge
SEC ↗0001193125-24-216607
Click to read coalition annotation ↓
July 22, 2024
CORRESP
SEC Staff Comment Letter — Round 2B (Jul 2024)
SECCORRESPFY2023disclosure-challenge
SEC ↗0001193125-24-182279
Click to read coalition annotation ↓
July 15, 2024
CORRESP
SEC Staff Comment Letter — Round 2A (Jul 2024)
SECCORRESPFY2023disclosure-challenge
SEC ↗0001193125-24-179065
Click to read coalition annotation ↓
May 7, 2024
CORRESP
SEC Staff Comment Letter — Round 1B (May 2024)
SECCORRESPFY2023disclosure-challenge
SEC ↗0001193125-24-133468
Click to read coalition annotation ↓
April 18, 2024
DEF 14A
Proxy Statement — 2024 Annual Meeting
proxyexecutive-compensationGeislerFTC-overlap
SEC ↗0001140361-24-020435
Click to read coalition annotation ↓
March 15, 2024
CORRESP
SEC Staff Comment Letter — Initial Challenge to FY2023 10-K
SECCORRESPFY2023disclosure-challengerestatement-origin
SEC ↗0001193125-24-069262
Click to read coalition annotation ↓
2023
March 31, 2023
DEF 14A
Proxy Statement — 2023 Annual Meeting
proxyexecutive-compensationGeislerFTC-period
SEC ↗0001140361-23-015111
Click to read coalition annotation ↓
February 1, 2023
CORRESP
SEC Staff Comment Letter — FY2022 10-K Review
SECCORRESPFY2022
SEC ↗0001193125-23-021695
Click to read coalition annotation ↓
2022
April 5, 2022
DEF 14A
Proxy Statement — 2022 Annual Meeting
proxyexecutive-compensationpost-IPOGeisler
SEC ↗0001140361-22-013141
Click to read coalition annotation ↓
April 4, 2022
CORRESP
SEC Staff Comment Letter — Post-IPO Annual Report Review (2)
SECCORRESPFY2021post-IPO
SEC ↗0001193125-22-095155
Click to read coalition annotation ↓
April 4, 2022
CORRESP
SEC Staff Comment Letter — Post-IPO Annual Report Review (1)
SECCORRESPFY2021post-IPO
SEC ↗0001193125-22-095149
Click to read coalition annotation ↓
2021
July 22, 2021
CORRESP
SEC Staff Comment Letter — Final IPO S-1 Review
SECCORRESPIPOS-1FTC-origin
SEC ↗0001193125-21-221336
Click to read coalition annotation ↓
July 22, 2021
S-1/A
IPO Registration Amendment — Final S-1/A (Jul 2021)
IPOS-1registrationFTC-originearnings-representations
SEC ↗0001193125-21-221333
Click to read coalition annotation ↓
July 20, 2021
CORRESP
SEC Staff Comment Letter — Pre-IPO S-1/A Review (2)
SECCORRESPIPOS-1
SEC ↗0001193125-21-219414
Click to read coalition annotation ↓
July 20, 2021
CORRESP
SEC Staff Comment Letter — Pre-IPO S-1/A Review (1)
SECCORRESPIPOS-1
SEC ↗0001193125-21-219409
Click to read coalition annotation ↓
July 16, 2021
S-1/A
IPO Registration Amendment — S-1/A (Jul 16, 2021)
IPOS-1registrationFTC-origin
SEC ↗0001193125-21-216585
Click to read coalition annotation ↓
July 15, 2021
CORRESP
SEC Staff Comment Letter — S-1/A Review (Mid-July 2021)
SECCORRESPIPOS-1
SEC ↗0001193125-21-216588
Click to read coalition annotation ↓
June 29, 2021
S-1/A
IPO Registration Amendment — S-1/A (Jun 2021)
IPOS-1registrationearnings-representations
SEC ↗0001193125-21-203392
Click to read coalition annotation ↓
June 25, 2021
CORRESP
SEC Staff Comment Letter — Initial IPO S-1 Review
SECCORRESPIPOS-1FTC-origin
SEC ↗0001193125-21-200658
Click to read coalition annotation ↓